BeOne Medicines
ONC
#625
Rank
A$57.45 B
Marketcap
A$519.25
Share price
-1.05%
Change (1 day)
27.97%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): A$0.85

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$0.92. In 2024 the company made an earnings per share (EPS) of A-$8.84.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.85-109.67%
2024A-$8.84
2022A-$27.6128.21%
2021A-$21.54-19.96%
2020A-$26.9120.81%
2019A-$22.2731.52%
2018A-$16.93417.57%
2017A-$3.27-37.16%
2016A-$5.21158.95%
2015A-$2.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.34-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.35-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA